Wyatt Bensken

Jun 4, 2024 | onlinelibrary.wiley.com | Siran M. Koroukian |Hannah L. Fein |Long Vu |Wyatt Bensken

We identified preexisting chronic conditions with excess prevalence in older adults with incident epilepsy compared to those without. We observed excess prevalence of most preexisting chronic conditions in older adults with incident epilepsy, especially for stroke. Excess prevalence was greater for younger than for older age groups. Excess prevalence was also greater in Hispanic beneficaries with incident epilepsy than in their non-Hispanic White and non-Hispanic Black counterparts.

Jan 5, 2024 | jamanetwork.com | Wyatt Bensken |Siran M. Koroukian |Brenda McGrath |Philip M. Alberti

Introduction The US Families First Coronavirus Response Act of the COVID-19 pandemic required states to provide continuous Medicaid coverage to receive additional federal funding.1 In April 2023, the Consolidated Appropriations Act required states to resume standard redeterminations,2 with large initial decreases in Medicaid enrollment.3 We studied a large national network of community health centers to assess Medicaid disenrollment during the first 6 months after the end of continuous...

Jun 7, 2023 | blogs.neurology.org | Wyatt Bensken

For people living with epilepsy, health care and health outcomes are influenced by a wide array of structural, socio-cultural, health care, and physiological factors.1 Due to this complex interplay of factors, it should not be surprising that several disparities between minoritized and non-minoritized people with epilepsy have been identified.2-8 Several of these disparities are better defined as inequities given that they are avoidable and unjust.9,10 As we continue to advance neurology...

May 30, 2023 | physiciansweekly.com | Wyatt Bensken |Siran M. Koroukian

Researchers identified wide-ranging disparities in the patterns of antiseizure mediation generation used across racial and ethnic groups. “Treatment-level decisions, such as patterns in antiseizure medication use, provide an interesting and compelling health equity indicator,” Wyatt P. Bensken, PhD, says. “There has been incredibly limited work to understand potential disparities and inequities in pharmacological treatment in neurology and certainly in epilepsy.